Selected research
Industry Research
Biobanking Sample Industry Research Report 2026
Market perspective
The global Biobanking Sample market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Biobanking Sample is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Biobanking Sample is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Biobanking Sample is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Biobanking Sample include Becton, Dickinson and Company (US), Biokryo GmbH (Germany), Brooks Automation (US), Chart Industries (US), Greiner Bio One [Greiner Holding AG, Austria)], Hamilton Company (US), LVL Technologies GmbH & Co. KG (Germany), Micronic (Netherlands) and Panasonic Healthcare Holdings Co. Ltd (Japan), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Biobanking Sample market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biobanking Sample Market by Company
Becton, Dickinson and Company (US)
Biokryo GmbH (Germany)
Brooks Automation (US)
Chart Industries (US)
Greiner Bio One [Greiner Holding AG, Austria)]
Hamilton Company (US)
LVL Technologies GmbH & Co. KG (Germany)
Micronic (Netherlands)
Panasonic Healthcare Holdings Co. Ltd (Japan)
Promega Corporation (US)
Qiagen N.V. (Germany)
Tecan Group Ltd. (Switzerland)
TTP Labtech Ltd (U.K.)
VWR Corporation (US)
Worthington Industries [(Taylor Wharton, US)]
Merck KGaA (Germany)
Thermo Fisher Scientific Inc(US)
Biobanking Sample Segment by Type
Nucleic Acids
Human Waste Products
Human Tissues
Biological Fluids
Cell Lines
Blood Products
Biobanking Sample Segment by Application
Clinical Research
Life Science Research
Regenerative Medicine
Biobanking Sample Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking Sample market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking Sample and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking Sample.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Biobanking Sample manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Biobanking Sample by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Biobanking Sample in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acids
- Human Waste Products
- Human Tissues
- Biological Fluids
- Cell Lines
- Blood Products
Applications
- Clinical Research
- Life Science Research
- Regenerative Medicine
Companies covered
- Becton, Dickinson and Company (US)
- Biokryo GmbH (Germany)
- Brooks Automation (US)
- Chart Industries (US)
- Greiner Bio One [Greiner Holding AG, Austria)]
- Hamilton Company (US)
- LVL Technologies GmbH & Co. KG (Germany)
- Micronic (Netherlands)
- Panasonic Healthcare Holdings Co. Ltd (Japan)
- Promega Corporation (US)
- Qiagen N.V. (Germany)
- Tecan Group Ltd. (Switzerland)
- TTP Labtech Ltd (U.K.)
- VWR Corporation (US)
- Worthington Industries [(Taylor Wharton, US)]
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc(US)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Biobanking Sample Market Size (2021-2032)
- 2.2.2 Global Biobanking Sample Sales (2021-2032)
- 2.2.3 Global Biobanking Sample Market Average Price (2021-2032)
- 2.3 Biobanking Sample by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Nucleic Acids
- 2.3.3 Human Waste Products
- 2.3.4 Human Tissues
- 2.3.5 Biological Fluids
- 2.3.6 Cell Lines
- 2.3.7 Blood Products
- 2.4 Biobanking Sample by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinical Research
- 2.4.3 Life Science Research
- 2.4.4 Regenerative Medicine
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Biobanking Sample Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Biobanking Sample Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Biobanking Sample Revenue of Manufacturers (2021-2026)
- 3.4 Global Biobanking Sample Average Price by Manufacturers (2021-2026)
- 3.5 Global Biobanking Sample Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Biobanking Sample, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Biobanking Sample, Product Type & Application
- 3.8 Global Manufacturers of Biobanking Sample, Established Date
- 3.9 Global Biobanking Sample Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Becton, Dickinson and Company (US)
- 4.1.1 Becton, Dickinson and Company (US) Company Information
- 4.1.2 Becton, Dickinson and Company (US) Business Overview
- 4.1.3 Becton, Dickinson and Company (US) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Becton, Dickinson and Company (US) Biobanking Sample Product Portfolio
- 4.1.5 Becton, Dickinson and Company (US) Recent Developments
- 4.2 Biokryo GmbH (Germany)
- 4.2.1 Biokryo GmbH (Germany) Company Information
- 4.2.2 Biokryo GmbH (Germany) Business Overview
- 4.2.3 Biokryo GmbH (Germany) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Biokryo GmbH (Germany) Biobanking Sample Product Portfolio
- 4.2.5 Biokryo GmbH (Germany) Recent Developments
- 4.3 Brooks Automation (US)
- 4.3.1 Brooks Automation (US) Company Information
- 4.3.2 Brooks Automation (US) Business Overview
- 4.3.3 Brooks Automation (US) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Brooks Automation (US) Biobanking Sample Product Portfolio
- 4.3.5 Brooks Automation (US) Recent Developments
- 4.4 Chart Industries (US)
- 4.4.1 Chart Industries (US) Company Information
- 4.4.2 Chart Industries (US) Business Overview
- 4.4.3 Chart Industries (US) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Chart Industries (US) Biobanking Sample Product Portfolio
- 4.4.5 Chart Industries (US) Recent Developments
- 4.5 Greiner Bio One [Greiner Holding AG, Austria)]
- 4.5.1 Greiner Bio One [Greiner Holding AG, Austria)] Company Information
- 4.5.2 Greiner Bio One [Greiner Holding AG, Austria)] Business Overview
- 4.5.3 Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Product Portfolio
- 4.5.5 Greiner Bio One [Greiner Holding AG, Austria)] Recent Developments
- 4.6 Hamilton Company (US)
- 4.6.1 Hamilton Company (US) Company Information
- 4.6.2 Hamilton Company (US) Business Overview
- 4.6.3 Hamilton Company (US) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hamilton Company (US) Biobanking Sample Product Portfolio
- 4.6.5 Hamilton Company (US) Recent Developments
- 4.7 LVL Technologies GmbH & Co. KG (Germany)
- 4.7.1 LVL Technologies GmbH & Co. KG (Germany) Company Information
- 4.7.2 LVL Technologies GmbH & Co. KG (Germany) Business Overview
- 4.7.3 LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Product Portfolio
- 4.7.5 LVL Technologies GmbH & Co. KG (Germany) Recent Developments
- 4.8 Micronic (Netherlands)
- 4.8.1 Micronic (Netherlands) Company Information
- 4.8.2 Micronic (Netherlands) Business Overview
- 4.8.3 Micronic (Netherlands) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Micronic (Netherlands) Biobanking Sample Product Portfolio
- 4.8.5 Micronic (Netherlands) Recent Developments
- 4.9 Panasonic Healthcare Holdings Co. Ltd (Japan)
- 4.9.1 Panasonic Healthcare Holdings Co. Ltd (Japan) Company Information
- 4.9.2 Panasonic Healthcare Holdings Co. Ltd (Japan) Business Overview
- 4.9.3 Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Product Portfolio
- 4.9.5 Panasonic Healthcare Holdings Co. Ltd (Japan) Recent Developments
- 4.10 Promega Corporation (US)
- 4.10.1 Promega Corporation (US) Company Information
- 4.10.2 Promega Corporation (US) Business Overview
- 4.10.3 Promega Corporation (US) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Promega Corporation (US) Biobanking Sample Product Portfolio
- 4.10.5 Promega Corporation (US) Recent Developments
- 4.11 Qiagen N.V. (Germany)
- 4.11.1 Qiagen N.V. (Germany) Company Information
- 4.11.2 Qiagen N.V. (Germany) Business Overview
- 4.11.3 Qiagen N.V. (Germany) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Qiagen N.V. (Germany) Biobanking Sample Product Portfolio
- 4.11.5 Qiagen N.V. (Germany) Recent Developments
- 4.12 Tecan Group Ltd. (Switzerland)
- 4.12.1 Tecan Group Ltd. (Switzerland) Company Information
- 4.12.2 Tecan Group Ltd. (Switzerland) Business Overview
- 4.12.3 Tecan Group Ltd. (Switzerland) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Tecan Group Ltd. (Switzerland) Biobanking Sample Product Portfolio
- 4.12.5 Tecan Group Ltd. (Switzerland) Recent Developments
- 4.13 TTP Labtech Ltd (U.K.)
- 4.13.1 TTP Labtech Ltd (U.K.) Company Information
- 4.13.2 TTP Labtech Ltd (U.K.) Business Overview
- 4.13.3 TTP Labtech Ltd (U.K.) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 TTP Labtech Ltd (U.K.) Biobanking Sample Product Portfolio
- 4.13.5 TTP Labtech Ltd (U.K.) Recent Developments
- 4.14 VWR Corporation (US)
- 4.14.1 VWR Corporation (US) Company Information
- 4.14.2 VWR Corporation (US) Business Overview
- 4.14.3 VWR Corporation (US) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 VWR Corporation (US) Biobanking Sample Product Portfolio
- 4.14.5 VWR Corporation (US) Recent Developments
- 4.15 Worthington Industries [(Taylor Wharton, US)]
- 4.15.1 Worthington Industries [(Taylor Wharton, US)] Company Information
- 4.15.2 Worthington Industries [(Taylor Wharton, US)] Business Overview
- 4.15.3 Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Product Portfolio
- 4.15.5 Worthington Industries [(Taylor Wharton, US)] Recent Developments
- 4.16 Merck KGaA (Germany)
- 4.16.1 Merck KGaA (Germany) Company Information
- 4.16.2 Merck KGaA (Germany) Business Overview
- 4.16.3 Merck KGaA (Germany) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Merck KGaA (Germany) Biobanking Sample Product Portfolio
- 4.16.5 Merck KGaA (Germany) Recent Developments
- 4.17 Thermo Fisher Scientific Inc(US)
- 4.17.1 Thermo Fisher Scientific Inc(US) Company Information
- 4.17.2 Thermo Fisher Scientific Inc(US) Business Overview
- 4.17.3 Thermo Fisher Scientific Inc(US) Biobanking Sample Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Thermo Fisher Scientific Inc(US) Biobanking Sample Product Portfolio
- 4.17.5 Thermo Fisher Scientific Inc(US) Recent Developments
5 Global Biobanking Sample Market Scenario by Region
- 5.1 Global Biobanking Sample Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Biobanking Sample Sales by Region: 2021-2032
- 5.2.1 Global Biobanking Sample Sales by Region: 2021-2026
- 5.2.2 Global Biobanking Sample Sales by Region: 2027-2032
- 5.3 Global Biobanking Sample Revenue by Region: 2021-2032
- 5.3.1 Global Biobanking Sample Revenue by Region: 2021-2026
- 5.3.2 Global Biobanking Sample Revenue by Region: 2027-2032
- 5.4 North America Biobanking Sample Market Facts & Figures by Country
- 5.4.1 North America Biobanking Sample Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Biobanking Sample Sales by Country (2021-2032)
- 5.4.3 North America Biobanking Sample Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Biobanking Sample Market Facts & Figures by Country
- 5.5.1 Europe Biobanking Sample Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Biobanking Sample Sales by Country (2021-2032)
- 5.5.3 Europe Biobanking Sample Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Biobanking Sample Market Facts & Figures by Country
- 5.6.1 Asia Pacific Biobanking Sample Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Biobanking Sample Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Biobanking Sample Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Biobanking Sample Market Facts & Figures by Country
- 5.7.1 South America Biobanking Sample Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Biobanking Sample Sales by Country (2021-2032)
- 5.7.3 South America Biobanking Sample Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Biobanking Sample Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Biobanking Sample Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Biobanking Sample Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Biobanking Sample Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Biobanking Sample Sales by Type (2021-2032)
- 6.1.1 Global Biobanking Sample Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Biobanking Sample Sales Market Share by Type (2021-2032)
- 6.2 Global Biobanking Sample Revenue by Type (2021-2032)
- 6.2.1 Global Biobanking Sample Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Biobanking Sample Revenue Market Share by Type (2021-2032)
- 6.3 Global Biobanking Sample Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Biobanking Sample Sales by Application (2021-2032)
- 7.1.1 Global Biobanking Sample Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Biobanking Sample Sales Market Share by Application (2021-2032)
- 7.2 Global Biobanking Sample Revenue by Application (2021-2032)
- 7.2.1 Global Biobanking Sample Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Biobanking Sample Revenue Market Share by Application (2021-2032)
- 7.3 Global Biobanking Sample Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Biobanking Sample Value Chain Analysis
- 8.1.1 Biobanking Sample Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Biobanking Sample Production Mode & Process
- 8.2 Biobanking Sample Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Biobanking Sample Distributors
- 8.2.3 Biobanking Sample Customers
9 Global Biobanking Sample Analyzing Market Dynamics
- 9.1 Biobanking Sample Industry Trends
- 9.2 Biobanking Sample Industry Drivers
- 9.3 Biobanking Sample Industry Opportunities and Challenges
- 9.4 Biobanking Sample Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst